Detailed information for compound 1622965

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 332.439 | Formula: C22H24N2O
  • H donors: 1 H acceptors: 1 LogP: 6.3 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccccc1c1ccc2c(c1)nc([nH]2)/C=C/C1CCCCC1
  • InChi: 1S/C22H24N2O/c1-25-21-10-6-5-9-18(21)17-12-13-19-20(15-17)24-22(23-19)14-11-16-7-3-2-4-8-16/h5-6,9-16H,2-4,7-8H2,1H3,(H,23,24)/b14-11+
  • InChiKey: ZJBJCXOJEOKRHB-SDNWHVSQSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Canis familiaris Transient receptor potential M8 protein Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Echinococcus granulosus transient receptor potential cation channel Transient receptor potential M8 protein   1104 aa 1114 aa 24.9 %
Schistosoma mansoni transient receptor potential cation channel subfamily m member Transient receptor potential M8 protein   1104 aa 1075 aa 25.3 %
Echinococcus multilocularis transient receptor potential cation channel Transient receptor potential M8 protein   1104 aa 1108 aa 25.5 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Toxoplasma gondii AGC kinase 0.0352 0.9337 1
Plasmodium falciparum RAC-beta serine/threonine protein kinase 0.0234 0.5959 1
Plasmodium vivax rac-beta serine/threonine protein kinase, putative 0.0234 0.5959 1
Trypanosoma cruzi Protein kinase B 0.0257 0.6622 1
Leishmania major protein kinase, putative,serine/threonine protein kinase, putative 0.0026 0 0.5
Echinococcus granulosus serine threonine protein kinase nrc 0.0234 0.5959 0.8303
Giardia lamblia Kinase, AGC PKA 0.0234 0.5959 0.5
Entamoeba histolytica protein kinase, putative 0.0375 1 1
Trichomonas vaginalis AGC family protein kinase 0.0144 0.3378 0.3378
Trichomonas vaginalis AGC family protein kinase 0.0375 1 1
Schistosoma mansoni serine/threonine-protein kinase 0.0257 0.6622 1
Echinococcus multilocularis nervana 2 0.0231 0.5885 0.8113
Leishmania major protein kinase, putative 0.0026 0 0.5
Entamoeba histolytica protein kinase, putative 0.0352 0.9337 0.9337
Brugia malayi p70 ribosomal S6 kinase beta 0.0352 0.9337 0.909
Trichomonas vaginalis AGC family protein kinase 0.012 0.2715 0.2715
Echinococcus multilocularis serine threonine protein kinase nrc serine threonine protein kinase gad 0.0234 0.5959 0.8303
Leishmania major protein kinase, putative 0.0026 0 0.5
Entamoeba histolytica PH domain containing protein kinase, putative 0.0257 0.6622 0.6622
Echinococcus granulosus calcium:calmodulin dependent protein kinase 0.0234 0.5959 0.8303
Entamoeba histolytica protein kinase 2, putative 0.0234 0.5959 0.5959
Echinococcus multilocularis Glutaredoxin protein 5 0.0231 0.5885 0.8113
Leishmania major rac serine-threonine kinase, putative,protein kinase, putative 0.0026 0 0.5
Trypanosoma cruzi rac serine-threonine kinase, putative 0.0257 0.6622 1
Entamoeba histolytica protein kinase, putative 0.012 0.2715 0.2715
Trichomonas vaginalis AGC family protein kinase 0.0375 1 1
Trypanosoma cruzi rac serine-threonine kinase, putative 0.0234 0.5959 0.8999
Trypanosoma brucei rac serine-threonine kinase, putative 0.0375 1 1
Leishmania major folate/biopterin transporter, putative 0.0026 0 0.5
Trichomonas vaginalis AGC family protein kinase 0.012 0.2715 0.2715
Echinococcus granulosus nervana 2 0.0231 0.5885 0.8113
Echinococcus multilocularis rac serine:threonine kinase 0.0257 0.6622 1
Entamoeba histolytica PH domain containing protein kinase, putative 0.0257 0.6622 0.6622
Trichomonas vaginalis serine/threonine-protein kinase sgk, putative 0.0118 0.2641 0.2641
Echinococcus multilocularis nervana 2 0.0231 0.5885 0.8113
Loa Loa (eye worm) AGC/RSK/P70 protein kinase 0.0352 0.9337 0.909
Loa Loa (eye worm) AGC/AKT protein kinase 0.0375 1 1
Trichomonas vaginalis AGC family protein kinase 0.012 0.2715 0.2715
Entamoeba histolytica protein kinase, putative 0.0375 1 1
Echinococcus granulosus Glutaredoxin protein 5 0.0231 0.5885 0.8113
Echinococcus granulosus sodium:potassium dependent atpase beta subunit 0.0231 0.5885 0.8113
Leishmania major serine/threonine-protein kinase a, putative 0.0026 0 0.5
Echinococcus granulosus nervana 2 0.0231 0.5885 0.8113
Echinococcus multilocularis sodium:potassium dependent atpase beta subunit 0.0231 0.5885 0.8113
Trichomonas vaginalis AGC family protein kinase 0.0375 1 1
Schistosoma mansoni serine/threonine-protein kinase 0.0257 0.6622 1
Echinococcus granulosus serine/threonine protein kinase 0.0257 0.6622 1
Trichomonas vaginalis AGC family protein kinase 0.0375 1 1
Trichomonas vaginalis AGC family protein kinase 0.0375 1 1
Trichomonas vaginalis AGC family protein kinase 0.0375 1 1
Trichomonas vaginalis AGC family protein kinase 0.0375 1 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 8.9 nM Antagonist activity at dog TRPM8 expressed in HEK293 cells assessed as inhibition of icilin-induced calcium flux by FLIPR assay ChEMBL. 22330635

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.